头豹研究院：中国皮肤湿疹外用制剂

Investment Rating - The report does not explicitly state an investment rating for the eczema ointment market in China Core Insights - The Chinese eczema ointment market is characterized by a growing demand for innovative solutions that balance efficacy and safety, driven by a trend of patient consumerization and the prevalence of unsafe products containing illegal hormone additives [5][7] - The report emphasizes that only products with the "National Drug Approval Number" can ensure safety and efficacy, highlighting the innovative non-hormonal drug, Zeli Mei® (Benvimod Cream), as a representative of future market direction [5][10] Summary by Sections Market Overview - Eczema is a chronic, recurrent inflammatory skin disease affecting 15% to 30% of dermatology patients, with topical medications accounting for 67% of treatment options [15][25] - Non-hormonal topical agents are crucial due to the potential adverse effects of long-term steroid use, with Benvimod Cream showing significant clinical advantages in efficacy and safety [15][21] Product Categories and Efficacy Analysis - The report outlines the importance of recognizing "National Drug Approval Number" products as the only legally validated treatment for eczema, with a focus on innovative drugs that enhance both efficacy and safety [10][42] - The market is transitioning from traditional to innovative drugs, with a notable increase in online pharmacy sales, reaching 1.78 billion yuan in Q2 2025, a year-on-year growth of over 37% [35][42] Patient Behavior and Awareness - The primary demographics of eczema patients in China are children (ages 2-12) and young adults (ages 18-60), with nearly 90% of cases being mild to moderate [48][54] - Patients prioritize ingredient safety and brand reputation when purchasing topical medications, with over 40% avoiding steroid treatments due to concerns about side effects [48][60] - The digital healthcare landscape is evolving, with e-commerce becoming a significant growth driver for dermatological products, as online medical consultations are increasingly popular [61][62] Market Issues and Analysis - The report identifies significant market issues, including the prevalence of misleading advertising and unsafe products, which pose serious health risks to consumers, particularly infants [9][10] - It stresses the need for strict regulatory measures to eliminate non-compliant products and promote a market focused on innovative, compliant drugs [10][42]